Showing results (411-420 of 1,024) with videos related to
Sort By:
Pageof 103
Purinergic Signalling|October 4, 2020
P2X7 is a cytotoxic receptor….maybe not: implications for cancerFrancesco Di VirgilioPurinergic Signalling|November 5, 2020
Purinergic signalling in the cardiovascular system-a tribute to Geoffrey BurnstockVera RalevicPurinergic Signalling|October 29, 2021
Pharmacological characterization of DPTN and other selective A3 adenosine receptor antagonistsZhan-Guo Gao, R Rama Suresh, Kenneth A JacobsonPurinergic Signalling|July 13, 2022
The P2X1 receptor as a therapeutic targetFelix M Bennetts, Jesse I Mobbs, Sabatino Ventura, et al.Purinergic Signalling|July 28, 2022
P2Y1R and P2Y2R: potential molecular triggers in muscle regenerationMin-Jia Wang, Bi-Ru Yang, Xin-Yu Jing, et al.Purinergic Signalling|January 16, 2016
Hyperglycemia alters E-NTPDases, ecto-5'-nucleotidase, and ectosolic and cytosolic adenosine deaminase activities and expression from encephala of adult zebrafish (Danio rerio)Katiucia Marques Capiotti, Anna Maria Siebel, Luiza Wilges Kist, et al.Purinergic Signalling|December 24, 2015
Intranasal guanosine administration presents a wide therapeutic time window to reduce brain damage induced by permanent ischemia in ratsDenise Barbosa Ramos, Gabriel Cardozo Muller, Guilherme Botter Maio Rocha, et al.Purinergic Signalling|February 11, 2016
Lack of effect of adenosine on the function of rodent osteoblasts and osteoclasts in vitroMark O R Hajjawi, Jessal J Patel, Michelangelo Corcelli, et al.Purinergic Signalling|December 16, 2014
NTPDase2 and the P2Y1 receptor are not required for mammalian eye formationKristine Gampe, Silke Haverkamp, Simon C Robson, et al.Purinergic Signalling|September 27, 2015
Supportive or detrimental roles of P2Y receptors in brain pathology?--The two faces of P2Y receptors in stroke and neurodegeneration detected in neural cell and in animal model studiesDaniel Förster, Georg ReiserPageof 103